Thrombin activates the p21-activated kinase in pulmonary artery smooth muscle cells. Role in tissue factor expression

Agnes Görlach1, Rachida S BelAiba, John Hess

  • 1Experimental Pediatric Cardiology, Department of Pediatric Cardiology and Congenital Heart Disease, German Heart Center Munich at the Technical University Munich, Lazarettstrasse 36 , 80636 Munich, Germany. goerlach@dhm.mhn.de

Insights

p21-activated kinases (PAK) are crucial for thrombin signaling in pulmonary artery smooth muscle cells. PAK regulates tissue factor expression, potentially contributing to vascular remodeling in pulmonary hypertension.

Area of Science:

  • Cellular biology
  • Molecular signaling
  • Cardiovascular research

Background:

  • p21-activated kinases (PAK) are vital for cellular functions.
  • The role of PAK in thrombin signaling and its impact on vascular remodeling, particularly in pulmonary hypertension, remains unclear.

Purpose of the Study:

  • To investigate the role of PAK in thrombin signaling pathways.
  • To determine PAK's involvement in regulating tissue factor (TF) expression in pulmonary artery smooth muscle cells (PASMC).

Main Methods:

  • Investigated PAK phosphorylation in response to thrombin in PASMC.
  • Utilized active and kinase-deficient PAK1 constructs to assess downstream signaling.
  • Examined the impact of PAK and other signaling molecules on TF expression and promoter activity.

Main Results:

  • Thrombin rapidly phosphorylated PAK in PASMC.
  • Active PAK (PAKT423E) and thrombin activated p38 MAP kinase (p38MAPK), ERK1/2, PDK1, and PKB.
  • Kinase-deficient PAK1 inhibited thrombin-induced activation of these kinases and TF expression.
  • Thrombin and active PAK1 increased TF expression and promoter activity.
  • Inhibition of MKK3, PDK1, or PKB attenuated thrombin- and PAK-dependent TF upregulation.

Conclusions:

  • PAK acts as a critical mediator in thrombin signaling within PASMC.
  • PAK sequentially activates MKK3/p38MAPK, PDK1, and PKB to regulate TF expression.
  • PAK signaling may significantly contribute to vascular remodeling processes in pulmonary hypertension.

Related Concept Videos

Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...